Mcneil And Argus Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Haryana, Haryana, India, established in 1988.
1988 Haryana, Haryana, India Active
Last Updated:
Access Report
About Mcneil And Argus Pharmaceuticals Limited

Mcneil And Argus Pharmaceuticals Limited, a active public limited company, was established on 10 March 1988 in Haryana, Haryana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231HR1988PLC030217. Registered under ROC Roc Haryana. it is unlisted. It has an authorized capital of ₹3.10 M and a paid-up capital of ₹1.19 M.

It upholds a compliant status. Its leadership includes Pawan Chhibber (Whole-Time Director), Gurdev Dutt Chhibber (Managing Director), Renu Chhibber (Whole-Time Director). Past directors included Pawan Chhibber, Gurdev Dutt Chhibber. It holds ₹4.87 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 100Rampur Sareri Road Ambalacantt.Ambala., Haryana, Haryana, 133001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231HR1988PLC030217

  • Registration Number

    030217

  • Incorporation Date

    10 March 1988

  • Authorized Capital

    ₹3.10 M

  • Paid-Up Capital

    ₹1.19 M

  • ROC Code

    Roc Haryana

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.10 M
  • Paid Up Capital ₹ 1.19 M
  • Company Age 37 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 4.87 Cr
  • Revenue Growth **** 70.93%
  • Profit Growth **** 104.24%
  • Ebitda **** 182.34%
  • Net Worth 123.01%
  • Total Assets **** 65.70%
Company report

Mcneil And Argus Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Mcneil And Argus Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Mcneil And Argus Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Pawan Chhibber Whole-Time Director 18 Jul 2005 Current
Gurdev Dutt Chhibber Managing Director 10 Mar 1988 Current
Renu Chhibber Whole-Time Director 11 Nov 1994 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Whole-Time Director 31 Mar 2018 Past
Pramod Abcsdd Managing Director 31 Mar 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Mcneil And Argus Pharmaceuticals.

Mcneil And Argus Pharmaceuticals Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 70.93% increase. The company also saw a substantial improvement in profitability, with a 104.24% increase in profit. The company's net worth Soared by an impressive increase of 123.01%.

Mcneil And Argus Pharmaceuticals revenue growth over time
Mcneil And Argus Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 70.93%
*******
*******
*******
*******
Revenue from Operations
*******
 69.37%
*******
*******
*******
*******
Total Assets
*******
 65.70%
*******
*******
*******
*******
Profit or Loss
*******
 104.24%
*******
*******
*******
*******
Net Worth
*******
 123.01%
*******
*******
*******
*******
EBITDA
*******
 182.34%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Mcneil And Argus Pharmaceuticals?

In 2020, Mcneil And Argus Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹48,700,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 4.87 Cr
Latest Charge Details
Date Lender Amount Status
27 Mar 2024 Others ₹4.87 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Mcneil And Argus Pharmaceuticals?

Unlock and access historical data on people associated with Mcneil And Argus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Mcneil And Argus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mcneil And Argus Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Mcneil And Argus Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Mcneil And Argus Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Mcneil And Argus Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana. was recorded as a recent event.

  • Charges

    A charge with Others amounted to Rs. 48.70 M with Charge ID 100897433 was registered on 27 Mar 2024. was recorded as a recent event.

  • Director Appointment

    Pawan Chhibber was appointed as a Whole-time director was appointed as a Whole-time director on 18 Jul 2005 & has been associated with this company since 20 years 7 months . was recorded as a recent event.

  • Director Appointment

    Renu Chhibber was appointed as a Whole-time director was appointed as a Whole-time director on 11 Nov 1994 & has been associated with this company since 31 years 3 months . was recorded as a recent event.

  • Director Appointment

    The activity Gurdev Dutt Chhibber was appointed as a Managing Director was appointed as a Managing Director on 10 Mar 1988 & has been associated with this company since 37 years 11 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Mcneil And Argus Pharmaceuticals Limited?

The CIN of Mcneil And Argus Pharmaceuticals Limited is U24231HR1988PLC030217.

Where is Mcneil And Argus Pharmaceuticals Limited headquartered?

Mcneil And Argus Pharmaceuticals Limited is headquartered at 100Rampur Sareri Road Ambalacantt.Ambala., Haryana, Haryana, 133001.

When was Mcneil And Argus Pharmaceuticals Limited incorporated?

Mcneil And Argus Pharmaceuticals Limited was incorporated on 10 March 1988.

Who are the current directors of Mcneil And Argus Pharmaceuticals Limited?

The current directors of Mcneil And Argus Pharmaceuticals Limited are

What is the primary industry of Mcneil And Argus Pharmaceuticals Limited?

The primary industry of Mcneil And Argus Pharmaceuticals Limited is Manufacturing.

Is Mcneil And Argus Pharmaceuticals Limited a listed company?

Mcneil And Argus Pharmaceuticals Limited is unlisted.

What is the capital structure of Mcneil And Argus Pharmaceuticals Limited?

The authorized capital of Mcneil And Argus Pharmaceuticals Limited is ₹3.10 M, and the paid-up capital is ₹1.19 M.

What is the compliance status of Mcneil And Argus Pharmaceuticals Limited?

The compliance status of Mcneil And Argus Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available